文献速递乳房整形与再造

乳房植入物疾病再审视:植入物乳房再造女性健康症状的队列研究

Breast implant illness revisited: A cohort study of health symptoms in women with implant-based reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-01-25

本研究为回顾性队列研究,纳入254例乳腺癌术后植入物乳房再造女性与487例保乳或单纯乳房切除对照,链接荷兰乳房植入物登记(2015-2019)与全科电子健康记录(2014-2022),评估13项乳房植入物疾病相关症状及就诊次数。随访3年内未见症状发生显著差异,植入物组就诊次数未增多,但植入后第1、2年≥3次就诊的可能性较植入前增加。

要点

  • 乳腺癌术后植入物再造女性中未发现乳房植入物疾病的证据。
  • 植入后3年内症状发生与对照相比无显著差异,就诊次数未增多。
  • 植入后第1、2年≥3次就诊的可能性较植入前增加。

核心结论

  • 本研究是首个仅聚焦乳腺癌术后植入物乳房再造女性的乳房植入物疾病研究,在该人群中未发现乳房植入物疾病的证据。
  • 乳房植入物疾病症状可能不在3年内出现而可能更晚出现,需更长随访的进一步研究。

研究设计与样本

  • 回顾性队列研究,纳入254例乳腺癌治疗后接受植入物乳房再造的女性,对照组为487例接受保乳治疗或单纯乳房切除的女性。
  • 链接荷兰乳房植入物登记数据(2015-2019年)与全科电子健康记录数据(2014-2022年),评估13项乳房植入物疾病相关健康症状在全科中的发生情况及这些症状的就诊次数,时间范围为乳房手术前1年至术后3年。

主要发现

  • 植入后3年内,比较植入前一年数据与对照组,症状发生无显著差异。
  • 随访期间,植入物组与对照组相比全科就诊次数未增多。
  • 与植入前相比,植入后第1年和第2年≥3次就诊的可能性增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 乳房植入物疾病症状可能不在3年时间内出现而可能更晚出现,需更长随访的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigated the association between silicone breast implants and health symptoms believed to be related to breast implant illness (BII) in women who underwent implant-based breast reconstruction after breast cancer. Although there is increasing evidence of an association between BII and breast augmentation cases, it is unclear in women with implant-based breast reconstruction. METHODS: This retrospective cohort study involved 254 women who underwent implant-based reconstruction after breast cancer treatment and a control group comprising 487 women who underwent breast-conservation therapy or simple mastectomy. We linked Dutch Breast Implant Registry data (2015-2019) and general practice electronic health records data (2014-2022) to study the occurrence of 13 BII-related health symptoms in general practice and number of consultations for these symptoms 1 year before to 3 years after breast surgery. RESULTS: Over the 3 years following implantation, no significant differences in symptom occurrence were observed when comparing the data from year before implantation and the control group. Women with breast implants did not have more consultations in general practice compared to the control group during follow-up. However, there was an increased likelihood of having ≥3 consultations in the first and second years post-implantation compared to that before implantation. CONCLUSIONS: This is the first study on BII focusing solely on women who underwent implant-based reconstruction after breast cancer. We found no evidence for BII in this patient group. However, BII symptoms may not manifest within the 3-year timeframe but could emerge later, which warrants further research with longer follow-up.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Lieffering AS, Hommes JE, van der Hulst RRWJ, et al. Breast implant illness revisited: A cohort study of health symptoms in women with implant-based reconstruction. J Plast Reconstr Aesthet Surg. 2025. PMID: 39919610. doi:10.1016/j.bjps.2025.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。